https://clinicaltrials.gov/ct2/show/NCT03506061?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=04%2F02%2F2019&lupd_d=14
Condition : Cystic Fibrosis
Intervention : Drug: Orkambi
Sponsors : Emory University; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
iPS Cell Response to CFTR Modulators
NCT03506061
Mon, 23 Apr 2018 12:00:00 EDT
Last Update Posted: 04/16/19 09:05AM